Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Maximus Inc. (MMS:NYSE), powered by AI.
Maximus Inc. is currently trading at $61.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Maximus Inc. on Alpha Lenz.
Maximus Inc.'s P/E ratio is 11.0.
“Maximus Inc. trades at a P/E of 11.0 (undervalued) with strong ROE of 18.1%.”
Ask for details →Maximus Inc. operates as a leading provider of health and human services worldwide. Its primary function is to offer business process services to government programs, focusing on delivering comprehensive administrative solutions and consultancy services that enhance public service delivery. Notably, Maximus serves healthcare, welfare, and employment industries, assisting governments in implementing and improving initiatives such as Medicaid and Medicare in the United States, as well as other international service programs. By managing complex processes and technology infrastructure, Maximus aids in optimizing efficiency and effectiveness for public sector clients. Headquartered in Reston, Virginia, Maximus Inc. holds a significant role in the market by bridging government operations with practical, efficiency-driven solutions. The company's influence extends globally as it partners with various governments to support program administration and ensure compliance with regulatory standards. Maximus is instrumental in facilitating citizen engagement and improving access to essential services, underscoring its importance in contributing to public health and economic resilience. By streamlining operations through technological and strategic expertise, Maximus continues to impact the delivery of critical social services across the world.
“Maximus Inc. trades at a P/E of 11.0 (undervalued) with strong ROE of 18.1%.”
Ask for details →Maximus Inc. (ticker: MMS) is a company listed on NYSE in the Industrials sector (Specialty Business Services). It has approximately 41,100 employees. Market cap is $3.5B.
The current price is $61.2 with a P/E ratio of 11.01x and P/B of 2.1x.
ROE is 18.14% and operating margin is 9.73%. Annual revenue is $5.4B.